Articles Tagged With: letermovir
-
Letermovir Prophylaxis Is Effective in Preventing Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation
A Phase III, randomized, double-blind, placebo-controlled superiority trial that included patients 18 years of age or older undergoing allogeneic hematopoietic stem cell transplantation found that prophylaxis with letermovir resulted in significantly lower risk for cytomegalovirus infection in the first 24 weeks than placebo. Safety and adverse events were similar between letermovir and placebo.